Navigation Links
Genenews adds two members to its Board of Directors

TORONTO, May 5 /PRNewswire-FirstCall/ - GeneNews Limited (TSX: GEN), a company focused on developing blood-based biomarker tests for the early detection of diseases and personalized health management, today announced its shareholders recently elected two additional members to its Board of Directors, Mr. Harry A. Glorikian and Ms. Fran Tuttle. They join Mr. Rory Riggs, Mr. James Howard-Tripp, Mr. Garth MacRae, Dr. Heiner Dreismann, Dr. C. C. Liew and Dr. K. Wayne Marshall on the Company's Board of Directors.

"We are pleased to welcome Mr. Glorikian and Ms. Tuttle to the GeneNews Board of Directors. Mr. Glorikian is currently the managing partner of Scientia Advisors, an international management and strategy consulting firm with a concentration in biotechnology and life sciences and Ms. Tuttle is President and Chief Executive Officer of HX Diagnostics, a diagnostics company in Emeryville, Ca., specialising in rapid diagnostics for seasonal and emerging infectious diseases," said K. Wayne Marshall, MD, PhD, President and Chief Executive Officer of GeneNews. "Their extensive experience in molecular diagnostics makes them timely additions to our Board as we prepare for the commercialization of our laboratory developed test (LDT) version of ColonSentry(TM), a blood-based molecular test to assess current risk for colorectal cancer. We expect to launch ColonSentry in Canada in the third quarter of this year."

Prior to becoming the Managing Partner at Scientia Advisors, Mr. Glorikian spent more than 8 years at Applied Biosystems in various roles, completing his tenure as Senior Manager, New Technology Assessment/Business Development. He was also the National Sales Manager for Signet Laboratories and a founder of X-Cell Laboratories, a clinical reference laboratory in San Francisco.

Ms. Tuttle is currently the President and CEO of HX Diagnostics. Throughout her career, she has developed and launched several major diagnostics products and had corporate experience at leading diagnostic companies including Bayer, Corning, Inc., Novartis, and Chiron. Ms. Tuttle was a Senior Vice President at Bayer Diagnostics responsible for a worldwide business of $400M. Most recently Ms. Tuttle was President and CEO of Protedyne, Inc., a robotics company developing automation solutions for molecular diagnostics and drug discovery, which was sold to LabCorp in 2007.

About GeneNews


GeneNews is focused on the application of functional genomics to enable early diagnosis and personalized therapeutic intervention based on disease-specific biomarkers. The Company has developed a novel approach, the Sentinel Principle(TM), to detect and stage virtually any disease or medical condition from a simple blood sample. GeneNews is currently applying the Sentinel Principle(TM) in major areas with unmet clinical needs such as cancer, arthritis, cardiovascular disease and neurological disorders. GeneNews' first product in development, ColonSentry(TM), is a convenient and patient-friendly blood-based test that can assess an individual's current risk for colorectal cancer. For more information on GeneNews, visit

This press release contains forward-looking statements, which reflect the Company's current expectations regarding future events. The forward-looking statements involve risks and uncertainties. Actual events could differ materially from those projected herein. Investors should consult the Company's ongoing quarterly filings and annual reports for additional information on risks and uncertainties relating to these forward-looking statements. The reader is cautioned not to rely on these forward-looking statements. The Company disclaims any obligation to update these forward-looking statements.

SOURCE GeneNews Limited
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. GeneNews CSO Dr. CC Liew awarded state honour by the Government of Malaysia
2. GeneNews Chief Scientist Dr. C.C. Liew co-editor of new genomics reference book
3. GeneNews initiates patient sample accrual for validation studies of colon cancer blood test
4. GeneNews receives ISO 13485 accreditation
5. GeneNews selected to present late-breaking abstract at AACR Annual Meeting
6. GeneNews announces 2007 year end results
7. GeneNews reports positive results from validation study of colorectal cancer biomarkers in late-breaking abstract at AACR
8. GeneNews Announces First Quarter Results
9. KGI Elects Three New Members to Board of Trustees
10. The Pittsburgh Life Sciences Greenhouse Elects Four New Members to Its Board of Directors
11. Stiefel Laboratories Appoints Two New Members to Board of Directors
Post Your Comments:
(Date:11/24/2015)... ... November 24, 2015 , ... In harsh ... Insertion points for in-line sensors can represent a weak spot where leaking process ... series of retractable sensor housings , which are designed to tolerate extreme process ...
(Date:11/24/2015)... , ... November 24, 2015 , ... ... OrthoAccel® Technologies, Inc., on being named to Deloitte's 2015 Technology Fast 500 list ... facility, OrthoAccel manufactures AcceleDent®, a FDA-cleared, Class II medical device that speeds up ...
(Date:11/24/2015)... ANGELES , Nov. 24, 2015 ... biotechnology company focused on the discovery, development and commercialization ... , Ph.D., Chief Executive Officer, is scheduled to present ... 1, 2015 at 10:50 a.m. EST, at The Lotte ... City . . ...
(Date:11/24/2015)... 24, 2015  PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI ... company,s president and chief executive officer, will present at the ... in New York City . The presentation ... 1, 2015 at 9:30 a.m. EST. ... website at least 15 minutes prior to the presentation to ...
Breaking Biology Technology:
(Date:11/17/2015)... PARIS , November 17, 2015 ... November 2015.   --> Paris from ... --> DERMALOG, the biometrics innovation leader, has invented the ... and fingerprints on the same scanning surface. Until now two ... fingerprints. Now one scanner can capture both on the same ...
(Date:11/17/2015)... Nov. 17, 2015  Vigilant Solutions announces today that ... Board of Directors. --> ... retiring from the partnership at TPG Capital, one of ... over $140 Billion in revenue.  He founded and led ... the TPG companies, from 1997 to 2013.  In his ...
(Date:11/16/2015)... , Nov 16, 2015  Synaptics Inc. (NASDAQ: ... interface solutions, today announced expansion of its TDDI ... touch controller and display driver integration (TDDI) ... smartphones. These new TDDI products add to the ... resolution), TD4302 (WQHD resolution), and TD4322 (FHD resolution) ...
Breaking Biology News(10 mins):